Structure-activity relationships of oral organosiloxanes on the male reproductive system.
D000284:Administration, Oral; D000311:Adrenal Glands / Q000187:drug effects; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D004357:Drug Synergism; D005837:Genitalia, Male / Q000187:drug effects*; D006529:Hepatomegaly / Q000139:chemically induced; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008297:Male; D051379:Mice; D009821:Oils / Q000009:adverse effects; D009829:Oleic Acids / Q000009:adverse effects; D009929:Organ Size; D011817:Rabbits; D051381:Rats; D012098:Reproduction / Q000187:drug effects*; D012828:Silicones / Q000008:administration & dosage* / Q000009:adverse effects; D012869:Skin Absorption / Q000187:drug effects; D013045:Species Specificity; D013329:Structure-Activity Relationship; D013739:Testosterone / Q000097:blood; D013997:Time Factors
D009821:Oils; D009829:Oleic Acids; D012828:Silicones; D013739:Testosterone; D002784:Cholesterol